Could positive Q4 earnings reverse Organigram's recent stock slide?
There's a bit of a conundrum occurring among cannabis companies this year. Quarterly revenue for some U.S. multistate operators (MSOs) is coming in at record levels. On the Canadian front, New Brunswick-headquartered Organigram (NASDAQ:OGI), one of the leading producers of indoor-grown cannabis and products made from it, posted double-digit revenue growth in its most recent quarter, alongside significant market share gains this year -- yet its shares have steadily sunk since February. Here's why that market disconnect might give investors a good opportunity to buy in.